New-York-Presbyterian stands as a premier destination for advanced therapies. Through unmatched expertise, groundbreaking treatments, and seamless care coordination, treatments are tailored to meet the needs of both patients and providers.
The next frontier in advanced care
Your patients deserve the highest standard of treatment
A wide spectrum of advanced therapies
NewYork-Presbyterian offers one of the most comprehensive cell and gene therapy programs available, with advanced treatments for cancer and more than 20 rare diseases. Across both standard-of-care options and clinical trials, our teams bring deep experience and access to therapies, matched by the support needed to help patients navigate the entire process.
Advanced therapies at NewYork-Presbyterian
- Abecma® (Myeloma)
- Adstiladrin® (Bladder cancer)
- Amtagvi® (Melanoma)
- Aucatzyl® (Leukemia)
- Blincyto® (Leukemia)
- Breyanzi® (Leukemia/Lymphoma)
- Carvykti® (Myeloma)
- Casgevy® (Sickle cell disease/Beta-thal)
- Columvi® (Lymphoma)
- Elevidys® (DMD)
- Elrexfio® (Myeloma)
- Elzonris® (Hem. malignancies)
- Encelto® (MacTel Type 2)
- Epkinly® (Lymphoma)
- Hemgenix® (Hemophilia B)
- Imdelltra® (Lung cancer)
- Itvisma® (SMA)
- Kimmtrak® (Melanoma)
- Kymriah® (Leukemia/Lymphoma)
- Lunsumio® (Lymphoma)
- Lutathera® (Gastroenteropancreatic cancer)
- Lyfgenia® (Sickle cell disease)
- MACI® (Full thickness cartilage defects)
- Otarmeni® (Inherited Deafness)
- Papzimeos® (Recurrent respiratory papillomatosis)
- Pluvicto® (Prostate cancer)
- Provenge® (Prostate cancer)
- Qalsody® (ALS)
- Rybrevant® (Lung cancer)
- Ryoncil® (SR-aGVHD)
- Spinraza® (SMA)
- Talvey® (Myeloma)
- Tecartus® (Leukemia/Lymphoma)
- Tecvayli® (Myeloma)
- Tregzi® (Leukemia)
- Tzield® (Type 1 Diabetes)
- Vabysmo® (Wet AMD)
- Yescarta® (Lymphoma)
- Zevaskyn® (RDEB)
- Zolgensma® (SMA)
- Zynteglo® (Beta-thal)
*All product names and registered trademarks are the property of their respective owners. Product references are provided for informational purposes only and do not imply endorsement by NewYork-Presbyterian.
A comprehensive care team for your patient's entire journey
Our dedicated care team guides each patient through every stage of cell or gene therapy, ensuring a seamless, fully supported experience from evaluation through recovery. Backed by a multidisciplinary team of specialists, support is continuous, integrated, and tailored to your patient.
Our locations
Clinical trials for cell and gene therapy
We’re highly committed to cell and gene therapy research to improve its effectiveness, reduce side effects, and extend its benefits to people with cancer and other rare diseases. We are working on clinical trials to bring these treatments to more patients in need.
Clinical trials at Weill Cornell Medicine
Clinical trials at Columbia University
Related news and stories
Insurance and eligibility
For healthcare providers, we offer unparalleled experience in navigating the complexities of advanced therapy coverage, having successfully treated hundreds of patients across all major payers. Our team has expertise in Specialty Care Agreements (SCAs) and Centers of Excellence (CoE) designations, along with proven pathways for securing authorization for high-cost therapies. This ensures your patients gain timely access to life-changing treatments while reducing administrative burdens for your practice.
Referring a patient
Share some basic information and a member of our team will be in touch to discuss your submission.